Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial.

French MA, Cozzi-Lepri A, Arduino RC, Johnson M, Achhra AC, Landay A; for the INSIGHT SMART Study Group.

AIDS. 2015 Feb 18. [Epub ahead of print]

PMID:
25695873
[PubMed - as supplied by publisher]
2.

Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease.

Weijmans M, de Bakker PI, van der Graaf Y, Asselbergs FW, Algra A, Jan de Borst G, Spiering W, Visseren FL; SMART Study Group.

Atherosclerosis. 2015 Feb 7;239(2):451-458. doi: 10.1016/j.atherosclerosis.2015.02.008. [Epub ahead of print]

PMID:
25687271
[PubMed - as supplied by publisher]
3.

Hemoglobin, hematocrit, and changes in cerebral blood flow: the Second Manifestations of ARTerial disease-Magnetic Resonance study.

van der Veen PH, Muller M, Vincken KL, Westerink J, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurobiol Aging. 2014 Dec 20. pii: S0197-4580(14)00835-5. doi: 10.1016/j.neurobiolaging.2014.12.019. [Epub ahead of print]

PMID:
25618615
[PubMed - as supplied by publisher]
4.

Cause-specific mortality and years of life lost in patients with different manifestations of vascular disease.

van Kruijsdijk RC, van der Graaf Y, Koffijberg H, Jan de Borst G, Nathoe HM, Jaap Kappelle L, Visseren FL; on behalf of the SMART study group.

Eur J Prev Cardiol. 2015 Jan 16. pii: 2047487314566998. [Epub ahead of print]

PMID:
25595551
[PubMed - as supplied by publisher]
5.

The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis.

Patel M, Pilcher J, Hancox RJ, Sheahan D, Pritchard A, Braithwaite I, Shaw D, Black P, Weatherall M, Beasley R; SMART Study Group.

NPJ Prim Care Respir Med. 2015 Jan 8;25:14099. doi: 10.1038/npjpcrm.2014.99.

PMID:
25569185
[PubMed - in process]
6.

Arterial stiffness and progression of structural brain changes: The SMART-MR study.

Jochemsen HM, Muller M, Bots ML, Scheltens P, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurology. 2015 Feb 3;84(5):448-55. doi: 10.1212/WNL.0000000000001201. Epub 2014 Dec 31.

PMID:
25552578
[PubMed - in process]
7.

Methodology of the stroke self-management rehabilitation trial: an international, multisite pilot trial.

Jones KM, Bhattacharjee R, Krishnamurthi R, Blanton S, Theadom A, Barker-Collo S, Thrift A, Parmar P, Maujean A, Ranta A, Sanya E, Feigin VL; SMART Study Group.

J Stroke Cerebrovasc Dis. 2015 Feb;24(2):297-303. doi: 10.1016/j.jstrokecerebrovasdis.2014.08.029. Epub 2014 Dec 10.

PMID:
25498738
[PubMed - in process]
8.

The interdependence between cardiovascular calcifications in different arterial beds and vascular risk factors in patients at high cardiovascular risk.

Takx RA, Zanen P, Leiner T, van der Graaf Y, de Jong PA; SMART study group.

Atherosclerosis. 2015 Jan;238(1):140-6. doi: 10.1016/j.atherosclerosis.2014.11.024. Epub 2014 Nov 29.

PMID:
25485737
[PubMed - in process]
9.

The relation between resting heart rate and cancer incidence, cancer mortality and all-cause mortality in patients with manifest vascular disease.

van Kruijsdijk RC, van der Graaf Y, Bemelmans RH, Nathoe HM, Peeters PH, Visseren FL; SMART Study Group.

Cancer Epidemiol. 2014 Dec;38(6):715-21. doi: 10.1016/j.canep.2014.09.004. Epub 2014 Oct 17.

PMID:
25448083
[PubMed - in process]
10.

Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.

Patel M, Pilcher J, Reddel HK, Qi V, Mackey B, Tranquilino T, Shaw D, Black P, Weatherall M, Beasley R; SMART Study Group.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):751-8. doi: 10.1016/j.jaip.2014.06.001. Epub 2014 Jul 25.

PMID:
25439367
[PubMed - in process]
11.

Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.

van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW, Spiering W, Visseren FL; SMART Study Group.

PLoS One. 2014 Jun 30;9(6):e101082. doi: 10.1371/journal.pone.0101082. eCollection 2014.

PMID:
24979386
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Metabolic syndrome, prediabetes, and brain abnormalities on mri in patients with manifest arterial disease: the SMART-MR study.

Tiehuis AM, van der Graaf Y, Mali WP, Vincken K, Muller M, Geerlings MI; SMART Study Group.

Diabetes Care. 2014 Sep;37(9):2515-21. doi: 10.2337/dc14-0154. Epub 2014 Jun 19.

PMID:
24947788
[PubMed - in process]
13.

Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.

Pilcher J, Patel M, Smith A, Davies C, Pritchard A, Travers J, Black P, Weatherall M, Beasley R, Harwood M; SMART Study Group.

Respirology. 2014 Aug;19(6):842-51. doi: 10.1111/resp.12319. Epub 2014 Jun 2.

PMID:
24889937
[PubMed - in process]
Free Article
14.

The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease.

van der Leeuw J, van der Graaf Y, Nathoe HM, de Borst GJ, Kappelle LJ, Visseren FL; SMART study group.

Heart. 2014 Sep 15;100(18):1421-9. doi: 10.1136/heartjnl-2014-305490. Epub 2014 May 9.

PMID:
24817441
[PubMed - indexed for MEDLINE]
15.

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.

Peters L, Neuhaus J, Duprez D, Neaton JD, Tracy R, Klein MB, Mocroft A, Rockstroh J, Dore G, Lundgren JD; INSIGHT SMART Study Group.

J Clin Virol. 2014 Jul;60(3):295-300. doi: 10.1016/j.jcv.2014.03.017. Epub 2014 Apr 8.

PMID:
24793968
[PubMed - indexed for MEDLINE]
16.

Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.

Miller CJ, Baker JV, Bormann AM, Erlandson KM, Huppler Hullsiek K, Justice AC, Neuhaus J, Paredes R, Petoumenos K, Wentworth D, Winston A, Wolfson J, Neaton JD; INSIGHT SMART Study Group; ESPRIT Study Group.

PLoS One. 2014 Apr 11;9(4):e95061. doi: 10.1371/journal.pone.0095061. eCollection 2014.

PMID:
24728071
[PubMed - in process]
Free PMC Article
17.

Parental history and the risk of subsequent vascular events in patients with clinically manifest vascular disease: the effects of sex of the parent and vascular disease location.

Weijmans M, van der Graaf Y, de Borst GJ, Nathoe HM, Algra A, Visseren FL; SMART study group.

Atherosclerosis. 2014 May;234(1):129-35. doi: 10.1016/j.atherosclerosis.2014.02.018. Epub 2014 Mar 3.

PMID:
24650753
[PubMed - indexed for MEDLINE]
18.

Factors associated with D-dimer levels in HIV-infected individuals.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD; INSIGHT SMART Study Group; ESPRIT Study Group; SILCAAT Scientific Committee.

PLoS One. 2014 Mar 13;9(3):e90978. doi: 10.1371/journal.pone.0090978. eCollection 2014.

PMID:
24626096
[PubMed - in process]
Free PMC Article
19.

Brain volumes and risk of cardiovascular events and mortality. The SMART-MR study.

van der Veen PH, Muller M, Vincken KL, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Neurobiol Aging. 2014 Jul;35(7):1624-31. doi: 10.1016/j.neurobiolaging.2014.02.003. Epub 2014 Feb 6.

PMID:
24582641
[PubMed - indexed for MEDLINE]
20.

Short-acting β-agonist use as a marker of current asthma control.

Patel M, Pilcher J, Munro C, Hosking A, Pritchard A, Shaw D, Black P, Weatherall M, Beasley R; SMART Study Group.

J Allergy Clin Immunol Pract. 2013 Jul-Aug;1(4):370-7. doi: 10.1016/j.jaip.2013.04.008. Epub 2013 Jun 5.

PMID:
24565542
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk